Description

Health Canada reviewed the potential risk of severe bone damage (osteonecrosis) with bisphosphonate use because of product information updates in Europe that warn about the risk of severe bone damage in the outer part of the ear canal. Previously, Health Canada completed a safety review of the risk of severe jawbone damage associated with bisphosphonate use. Therefore, the current safety review focused on severe bone damage other than to the jawbone.

Resources

Name	Format	Description	Link
Summary Safety Review - Bisphosphonates - Assessing the Potential Risk of Severe Bone Damage (osteonecrosis)	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/summary-safety-review-bisphosphonates-assessing-potential-risk-severe-bone.html
Summary Safety Review - Bisphosphonates - Assessing the Potential Risk of Severe Bone Damage (osteonecrosis)	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/examens-innocuite/resume-examen-innocuite-bisphosphonates-evaluation-risque-potentiel-lesions-osseuses.html

Tags

Topics

Categories